Pfizer

Pfizer News

FDA authorizes first COVID-19 shots for infants, preschoolers; vaccinations to begin next week
World

FDA authorizes first COVID-19 shots for infants, preschoolers; vaccinations to begin next week

The Food and Drug Administration's action follows its advisory panel's unanimous recommendation for the shots from Moderna and Pfizer. That means US kids under 5, roughly 18 million youngsters, are eligible for the shots

Explained: The controversy around Paxlovid treatment for COVID-19 and 'rebound illness'
World

Explained: The controversy around Paxlovid treatment for COVID-19 and 'rebound illness'

While the US government is purchasing more Paxlovid, patients, scientists and even federal agencies are uncertain about its effectiveness as in several cases people have complained of experiencing a second round of symptoms in what is being called as “rebound illness” or 'Paxlovid rebound'

WHO 'strongly recommends' Pfizer's COVID-19 pill: Five things to know about Paxlovid
India

WHO 'strongly recommends' Pfizer's COVID-19 pill: Five things to know about Paxlovid

WHO's recommendation was based on the findings of two trials involving almost 3,100 patients which showed that Paxlovid reduced the risk of hospital admission by 85 percent

India's 'warm vaccine' candidate effective against Delta, Omicron COVID-19 variants in mice, says study
India

India's 'warm vaccine' candidate effective against Delta, Omicron COVID-19 variants in mice, says study

The latest study, published recently in the journal Viruses, assessed vaccinated mice sera (blood samples) for efficacy against key coronavirus variants, including Delta and Omicron.

US authorises new antibody drug bebtelovimab to fight Omicron
Health

US authorises new antibody drug bebtelovimab to fight Omicron

The Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19 that also works against the emerging BA.2 mutation of Omicron

Pfizer asks FDA to allow extra-low doses of COVID-19 vaccine for kids under 5
Health

Pfizer asks FDA to allow extra-low doses of COVID-19 vaccine for kids under 5

The FDA's decision could come within the month, but that isn't the only hurdle, the Centers for Disease Control and Prevention also has to sign off for steps to be initiated

COVID-19: Moderna begins clinical trials of Omicron-specific vaccine booster
Health

COVID-19: Moderna begins clinical trials of Omicron-specific vaccine booster

This comes a day after rivals Pfizer and BioNTech said they had begun enrollment for a clinical trial for an Omicron-specific vaccine

Unilever to lay off 1,500 employees after failed GSK-Pfizer unit takeover bid
Business

Unilever to lay off 1,500 employees after failed GSK-Pfizer unit takeover bid

The announcement comes after Unilever failed with a $68-billion takeover bid for the consumer health care unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer

FDA expands Pfizer boosters for children as young as 12 years as omicron surges in US
World

FDA expands Pfizer boosters for children as young as 12 years as omicron surges in US

Boosters already are recommended for everyone 16 and older, and federal regulators on Monday decided they’re also warranted for 12- to 15-year-olds once enough time has passed since their last dose

Israel approves fourth COVID-19 vaccine dose for most vulnerable as cases surge
World

Israel approves fourth COVID-19 vaccine dose for most vulnerable as cases surge

Israel was among the first countries to roll out Pfizer's coronavirus vaccine a year ago and began rolling out boosters last summer

Omicron can evade protection offered by COVID-19 vaccines, antibody therapies, says study
Health

Omicron can evade protection offered by COVID-19 vaccines, antibody therapies, says study

The study, published in the journal Nature on Thursday, also highlights the need for new vaccines and treatments that anticipate how the SARS-CoV-2 virus may soon evolve.

US regulator FDA authorises Merck's COVID-19 pill for high risk adults
World

US regulator FDA authorises Merck's COVID-19 pill for high risk adults

The FDA has not authorized Merck's pill for people under 18 because it may affect bone and cartilage growth.

Pfizer says its COVID pill cuts risk of hospitalisation among high-risk adults by 89 percent
World

Pfizer says its COVID pill cuts risk of hospitalisation among high-risk adults by 89 percent

Separate laboratory testing shows the drug retains its potency against the omicron variant, the company announced, as many experts had predicted

Do vaccines work against Omicron and what is their efficacy? Here’s what experts say
World

Do vaccines work against Omicron and what is their efficacy? Here’s what experts say

Preliminary results from a small study in South Africa suggested there was up to a 40-fold drop in the ability of the antibodies from the Pfizer-BioNTech vaccine to neutralise Omicron

Merriam-Webster chooses vaccine as 2021 word of the year as world puts up fight against COVID-19
World

Merriam-Webster chooses vaccine as 2021 word of the year as world puts up fight against COVID-19

Compared to 2019, when there was little urgency or chatter about vaccines, Merriam-Webster logged an increase of 1,048 percent in lookups this year

COVID-19: Pfizer agrees to let other companies make its experimental VOID-19 pill
World

COVID-19: Pfizer agrees to let other companies make its experimental VOID-19 pill

Health officials said the fact that the deal was struck even before Pfizer's pill has been authorized anywhere, could help to end the pandemic quicker

Two new antiviral drugs join the war against COVID-19; here's a look at their efficacy
World

Two new antiviral drugs join the war against COVID-19; here's a look at their efficacy

COVID-19 vaccines have been successful in preventing severe disease, but the deployment of these antivirals will still be significant given that vaccines aren’t protective 100 percent of the time

Pfizer says its Covid antiviral pill cuts down hospitalisation risk by 89%
World

Pfizer says its Covid antiviral pill cuts down hospitalisation risk by 89%

Currently all COVID-19 treatments used in the US require an IV or injection

COVID-19 Fact Check: The Pfizer COVID vaccine is safe for children aged 5-11 years says FDA
World

COVID-19 Fact Check: The Pfizer COVID vaccine is safe for children aged 5-11 years says FDA

The FDA assessed the safety of the kid-size doses in 3,100 vaccinated youngsters and has said that kids between 5 to 11 years will get just a third of the dose given to teens and adults.

US gives final clearance to Pfizer's COVID-19 vaccine shot for children between 5 to 11 years
World

US gives final clearance to Pfizer's COVID-19 vaccine shot for children between 5 to 11 years

The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine